Reduced microglial immunoreactivity for endogenous NMDA receptor agonist quinolinic acid in the hippocampus of schizophrenia patients

Tomasz Gos, Aye-Mu Myint, Kolja Schiltz, Gabriela Meyer-Lotz, Henrik Dobrowolny, Stefan Busse, Ulf J. Mueller, Christian Mawrin, Hans-Gert Bernstein, Bernhard Bogerts, Johann Steiner

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)59-64
JournalBrain Behavior and Immunity
Volume41
DOIs
Publication statusPublished - Oct 2014

Keywords

  • Schizophrenia
  • Microglia
  • Quinolinic acid
  • Glutamate
  • Hippocampal formation
  • Hippocampus

Cite this

Gos, T., Myint, A-M., Schiltz, K., Meyer-Lotz, G., Dobrowolny, H., Busse, S., Mueller, U. J., Mawrin, C., Bernstein, H-G., Bogerts, B., & Steiner, J. (2014). Reduced microglial immunoreactivity for endogenous NMDA receptor agonist quinolinic acid in the hippocampus of schizophrenia patients. Brain Behavior and Immunity, 41, 59-64. https://doi.org/10.1016/j.bbi.2014.05.012